Promotion of Cardiovascular Health in Africa Authors: Mame Madjiguene KA, Ngone Diaba Gaye, Dzifa Ahadzi, Carissa M Baker-Smith, Serigne Cheikh Tidiane Ndao, Vivien Wambugu, Gurbinder Singh, Khadidiatou Gueye, Daouda Seck, Khadidiatou Dia, Norrina Bai Allen, Awa Ba, Waly Niang Mboup, Rabab Yassine, Pape Momar Guissé, Malick Anne, Fatou Aw, Serigne Mor Bèye, Marguerite Tening Diouf, Mor Diaw, Jamal Belkhadir, Issa Wone, Jamal Eddine Kohen, Maïmouna Ndour Mbaye, Aliou Alassane Ngaide, Elisabeth Alice Liyong, Ndeye Marième Sougou, Mathias Lalika, Boni Maxime Ale, Lamin Jaiteh, Demeke Mekonnen, Fred Bukachi, Thiess Lorenz, Kauthrah Ntabadde, Warner Mampuya, Dismand Houinato, David Lagoro Kitara, Abdoul Kane, Sidy Mouhamed Seck, Ibrahima Socé Fall Published: 2024 ABSTRACT AbstractThis proposed scientific statement is focused on providing new insights regarding challenges and opportunities for cardiovascular health (CVH) promotion in Africa. The statement includes an overview of the current state of CVH in Africa, with a particular interest in the cardiometabolic risk factors and their evaluation through metrics. The statement also explains the main principles of primordial prevention, its relevance in reducing noncommunicable disease and the different strategies that have been effective worldwide. Also, the statement addresses challenges for implementing primordial prevention strategies in Africa, such as socioeconomic, cultural, lifestyle, and environmental factors, and highlights the importance of adapting strategies to the context. Finally, the statement recommends fundamental approaches for promoting CVH with the help of various partnerships and the involvement of communities.Key words: Africa, cardiovascular health, diabetes, hypertension, obesity, primordial prevention Cardiovascular diseases (CVDs) are the leading cause of death worldwide, and their burden is increasing disproportionately in many low- and middle-income countries, including those in Africa.1 Despite advances in medical treatments and interventions, preventing CVD remains a critical public health priority, particularly in regions where resources for treatment and care are limited. Promoting a healthy lifestyle that includes physical activity, a healthy diet, and the management of cardiovascular risk factors such as high blood pressure, diabetes mellitus, dyslipidemia, and obesity is essential for preventing CVDs. In addition to individual risk factors and interventions, the European Society of Cardiology and the European Association of Preventive Cardiology recommended policy interventions at the population level in their 2021 guidelines.2 The American Heart Association did similar in 2022 by publishing Life’s Essential 8.3 These recent guidelines included evidence-based guidance to modify specific social determinants of health, promote healthy behaviors, and reduce exposure to risk factors, with political support.2,3 More information is needed to understand the adaptability of these recommendations to Africa. African countries face a high burden of communicable and noncommunicable diseases (NCDs), but resources for health care and health promotion are limited. Cultural beliefs, practices, and socioeconomic factors can also impact adopting healthy behaviors.4, 5, 6 Furthermore, environmental factors such as air pollution and limited access to healthy foods can contribute to the development of CVDs.7 This overview assesses the relevance of recommended interventions for cardiovascular health (CVH) promotion in Africa. It highlights the challenges to implementing them in the region and suggests potential strategies for CVH promotion in a culturally sensitive and sustainable manner. Additionally, it emphasizes the importance of primordial prevention in reducing the burden of CVDs in Africa and provides recommendations for integrating primordial prevention into CVH promotion efforts. The Central Illustration provides a visual summary of our approach and steps. Promoting Cardiovascular Primordial Prevention in Africa CVD = cardiovascular disease; EMF = endomyocardial fibrosis. Current state of cardiovascular health in Africa In Africa, NCDs, particularly CVDs, are prevalent. CVDs account for 38.3% of deaths linked to NCDs and contribute to 22.9 million disability-adjusted life years,8,9 with the highest burden being in people younger than 30 years.10 Unlike most high-income countries, where cardiovascular deaths have decreased, Africa has experienced an almost 50% rise in the burden of CVDs over the past 30 years.11 The lack of funds and limited research capacity in sub-Saharan Africa (SSA) has hindered epidemiological research on CVD. Thus, the true burden of CVDs is unknown. However, hospital and community-based data show that the region is facing a double burden of diseases linked to infections and poverty, emerging cardiovascular issues brought on by the HIV/AIDS epidemic, and increasing cardiometabolic risk factors causing “diseases of affluence.”12 Cardiovascular diseases related to infection and poverty These conditions include untreated congenital heart disease, rheumatic heart disease, and cardiomyopathies and occur mainly in underprivileged communities. Poverty and CVDs have a bidirectional relationship: high rates of poverty and NCD lead to limited resource allocation for CVD prevention, contributing to increased CVD, and rising health care expenditures which push individuals and their families into poverty.13 In 2019, SSA had some of the highest estimated age-standardized rates of disability-adjusted life years and mortality due to rheumatic heart disease worldwide.14 Congenital heart disease prevalence might be largely underestimated due to a lack of diagnostic facilities, incomplete data, and poor outcomes but is currently estimated with the lowest prevalence in the world. Limited access to surgical programs leads to exceptionally high rates of morbidity (from complications like pulmonary hypertension, arrhythmias, and heart failure) and mortality.15 The incidence of peripartum cardiomyopathy seems to be higher among women of African descent.16 The true incidence and prevalence of peripartum cardiomyopathy among women in Africa is unknown.17 However, all-cause mortality related to peripartum cardiomyopathy appears to be highest in Africa and Asia.18 Although genetic predisposition and previous pregnancy-related diseases play a major role in the pathogenesis, other risk factors, such as viral infections and low socioeconomic status, have been associated with this condition.19,20 New cardiovascular issues from the HIV/AIDS epidemic HIV-associated CVDs include cardiomyopathy, pericarditis related to Mycobacterium tuberculosis in over 90% of cases, and pulmonary arterial hypertension.21 Antiretroviral therapy has improved life expectancy and reduced related conditions in people with HIV. However, it may also contribute to dyslipidemia and insulin resistance, increasing the cardiovascular risk in individuals living with HIV.21 Rise of cardiometabolic risk factors Cardiometabolic risk factors are rising in Africa due to rapid urbanization and globalization. Smoking status Tobacco smoking prevalence varies by country, with 45% to 60% reported in Morocco, Egypt, Cameroon, the Republic of Congo, Mauritius, and Sierra Leone, but only 9% and 13% in Ethiopia and Ghana, respectively. The population of tobacco users in SSA is expected to exceed 200 million by 2030.22,23 Overweight and obesity The prevalence of obesity in Africa is more important among women, in contrast to other regions of the world. Countries like Egypt and South Africa, which are experiencing rapid economic growth, have higher obesity rates (29% and 27%, respectively).22 Physical activity A 2009 study found a 13% physical inactivity rate in West Africa, with higher rates in rural areas, women, and older adults.24 A recent study of adolescents across 23 African countries showed that 30% of the study population engages in sedentary behavior, especially in Southern and East Africa.25 Healthy diet Africa faces both undernutrition and a rise in diet-related NCDs.26,27 Urbanization has led to a shift from a high-fiber diet to more refined, high-salt, fat-rich, and sugary diets.28 A 2011 World Health Organization survey reported that 67% of diets in the region were unhealthy.29 Total cholesterol Hypercholesterolemia is highest in Northern Africa (about 45%) and lowest in Western Africa (15% to 20%), with an average of 20% to 35% across the rest of Africa.22 A 2018 meta-analysis of population-based studies revealed a pool prevalence of elevated total cholesterol among adults of 25.5% (95% CI: 20.0%-31.4%).30 Blood pressure Hypertension is the primary risk factor for CVD in Africa, affecting 46% of those over 25 years.31,32 Elevated blood pressure heightens the risk of stroke and heart disease, particularly affecting younger populations. Many studies emphasized greater salt sensitivity among Black individuals due to genetic and epigenetic factors.33 Blood sugar Undiagnosed diabetes in Africa is 5.37%,34 with 77% of all diabetes-related deaths occurring in SSA.35 Healthy sleep A recent review found that 63.31% of university students in Africa have poor sleep quality linked to stress, bedtime electronic use, and chronic illness.36 For African women, cardiovascular issues are a major concern due to pregnancy-related conditions like gestational hypertension and diabetes, as well as untreated cardiac diseases. A Nigerian autopsy study found that CVD and eclampsia were the leading indirect causes of maternal deaths.37 Additionally, pregnancy complications can affect childhood development and increase cardiovascular risk later in life.38 Environmental risk factors have gained more interest in recent years. Africa is highly vulnerable to global warming, facing challenges like floods and deforestation.39 Rapid urbanization and industrialization contribute to air pollution, higher temperatures, and humidity. Nonetheless, conventional risk factors alone do not fully account for the high prevalence of CVD in a very young population on the continent. Further investigation is needed into additional environmental risk factors, such as social deprivation or the role of infections in premature cardiovascular aging. Primordial prevention Definition of primordial prevention Primordial prevention aims to prevent the development of risk factors by fostering an environment that supports healthy behaviors and discourages unhealthy ones. Unlike primary prevention, which manages existing risk factors, primordial prevention focuses on creating favorable social and environmental conditions through laws and policies. Multiple population-based cohort studies have shown a notable and continuous decrease in the risk of mortality and CVDs with improved CVH status,40 even in older adults.41 It has also been shown that primordial prevention slows the progression of subclinical vascular disease biomarkers.42 This approach is especially crucial in Africa, where health systems struggle with the increasing burden of CVDs. Importance of primordial prevention in reducing the burden of cardiovascular diseases Primordial prevention effectively reduces the incidence and prevalence of CVDs,43,44 by addressing root causes rather than just symptoms. It is especially important in Africa, where increasing rates of hypertension, diabetes, and obesity lead to more premature deaths,45 higher health care costs, and reduced productivity.46 With CVDs being the leading cause of death for those over 45 years of age, prioritizing cost-effective interventions is crucial. Geoffrey’s “prevention paradox” suggests that reducing risk factors across a whole population yields greater benefits than focusing only on high-risk individuals.47 Low-risk lifestyle has been shown to strongly predict outcomes across populations with different CVH manifestations in other populations.48 Primordial prevention can lower CVD rates, improve economic productivity, and reduce health care expenditure in developing countries by preventing the emergence of risk factors.49 Additionally, it can help reduce health disparities and prevent other NCDs. Across the globe, including in Africa, primordial prevention efforts must begin in childhood.50,51 Components of cardiovascular primordial prevention Primordial prevention involves lifestyle changes, reducing exposure to risk factors, and promoting health across populations.52 While interventions for lifestyle changes can be time-consuming and costly, they offer long-term benefits and improve quality of life.2 However, they have a slight impact on the population level.53 National strategies, which are known to be more cost-effective, include policy development (such as restrictions, economic incentives, and product labeling), environmental modifications, and public health campaigns. National programs should address all life stages, from conception to older age.3 Health education and promotion should be integrated into schools, workplaces, and community settings.2 Mass media campaigns effectively increase basic knowledge but often fail to correct misconceptions. To ensure sustainability, these campaigns must be simple, cost-effective, and designed to reach a broad audience. They should also support and incentivize health providers’ efforts.53 Table 1 summarizes various primordial prevention interventions tested globally.3 Table 1Examples of Interventions in Cardiovascular Primordial Prevention Tested Around the World (Adapted From Visseren et al2 and Lloyd-Jones et al3)Risk FactorPrinciplesInterventionsPhysical activityEncouraging physical activity by individualsUse of stairs, exercise prescription by physiciansPromoting physical activity in general populationIncluding cycling and pedestrian lanes in urban areas, tax-reduction incentives, expanded availability and variety of playground spaces and equipment, comprehensive wellness programs in worksites, improved walkability and esthetics in neighborhoodDiscouraging the use of individual motorized transportIncreased fuel taxes, increasing active commuting to school or workDietPromoting healthy eating habitsEducation and information campaigns on social media or schools to raise awareness among consumers on nutritional quality of food, multicomponent, and comprehensive nutritional programs at schools and preschoolsImproving access to healthy foodsLegislation on composition and food beverages to reduce energy density, salt, and fat content; supporting farming to enhance availability of unprocessed local foodLimiting access to unhealthy foodsRegulation on the upper limit of industrially produced trans fats; restricting marketing, compulsory and standardized front-of-pack nutrition labeling; taxation on foods and drinks high in sugar, saturated fats, and alcohol; control over the placement and concentration of fast-food establishmentsSmoking and tobacco useDiscouraging tobacco use and smokingMedia and educational campaigns, banning tobacco smoking in certain areas, raising taxes, restrictions on advertising and marketing, standardizing border sales and tax-free sales for all tobacco products while banning sales to minorsEncouraging tobacco cessationTelephone and internet based-lines cessation counseling and support services, cigarette package pictorial and text warnings, being tobacco-free during pregnancy, at home and in the presence of childrenAlcoholLimiting alcohol useMulticomponent and comprehensive education on alcohol abuse, drink-driving countermeasures, sobriety checkpoints, restrictions and bans on advertising and marketingReducing access to alcoholReducing and regulating physical availability of alcohol beverages, public health-orientated licensing systemsEnvironmental pollutantsMeasures to reduce harmful emissionsFactory regulations, drinking water controls, adoption of “clean air” legislation, promotion of public transport, reducing household air pollution from burning biomass, energy transfer to renewable sources and avoidance of fossil fuels, reducing noise exposure. Examples of Interventions in Cardiovascular Primordial Prevention Tested Around the World (Adapted From Visseren et al2 and Lloyd-Jones et al3) Measuring and monitoring CVH Primordial prevention interventions should be monitored to assess their efficiency in reducing risk factors. “Life’s Essential 8” is a unique, standardized tool for assessing and tracking CVH in individuals and populations. This tool uses a score from 0 to 100, averaged from 8 component scores. Lloyd-Jones and colleagues suggested that CVH scores should be interpreted as follows: scores of 80 to 100 indicate high CVH, 50 to 79 represent moderate CVH, and 0 to 49 reflect low CVH. “Life’s Essential 8” is a potentially valuable tool for measuring and monitoring CVH in Africa and guiding future interventions.3 Challenges to implementing primordial prevention in Africa Implementing primordial prevention strategies in Africa may be challenging due to its unique context: diverse sociocultural factors, a developing economy with multiple priorities like quality education, food security, poor urban sanitation, political instability, environmental issues (such as industrial emissions, vehicle exhaust, and biomass burning), and weak health care systems. These complexities make establishing effective prevention programs difficult. Health system challenges African health systems face limitations in human and financial resources, coordination between care levels, and infrastructure and data systems. Additionally, the research environment is insufficient, with a lack of evidence for effective, context-specific interventions, such as those addressing the “Cardiovascular Health Paradox.”54,55 Identifying vulnerable groups with low CVH and higher risk of deterioration is crucial.56 These issues hinder the implementation, monitoring, and evaluation of prevention programs. There is also a need for universal health insurance, sufficient access, and affordable long-term CVD preventive medications. Socioeconomic constraints Insufficient funding and constrained public health budgets can impact the ability to launch large-scale prevention programs. Poverty can make it difficult for individuals to prioritize CVH with regard to the affordability of healthy food and access to quality medical services, especially in rural areas.57,58 Education and awareness Low health literacy, highlighted in many African studies, can hinder the adoption of healthy behaviors.59, 60, 61 Cultural practices and traditional beliefs may also impact the acceptance and implementation of modern prevention strategies. Some cultural norms may discourage or stigmatize healthy behaviors, such as a balanced diet, physical activity, or seeking medical care.58,62, 63, 64 Political and policy issues CVD prevention may be overlooked in national health policies when stakeholders are unaware of the current disease burden. Urgent national health crises may shift governmental focus from CVD care with dire consequences, as seen during the COVID-19 pandemic. Weak governance, corruption, lack of political will, and poor infrastructure may further exacerbate implementation gaps.65 Communication and technology Limited access to technology can impede health information dissemination and telemedicine services. Multiple language and communication barriers can affect the delivery and effectiveness of health education programs in a culturally appropriate context.66 Strategies for implementing primordial prevention in Africa Strategies should be tailored to Africa’s specific context, inspired by previous successful infectious disease prevention programs, and focus on 7 key objectives: Implementing quality epidemiological research Some African countries, like Malawi, Rwanda, and Ghana, are progressively building NCD research capacity through training courses, mentored research awards, long-term academic partnerships, and internship placement programs.67,68 These initiatives should lead to improved grant writing, new funding sources, robust data collection and surveillance systems, and high-quality actionable data. African stakeholders may determine research priorities when appropriately empowered rather than the proliferation of external organization-initiated research.69 Advocacy is needed for greater equity for African researchers facing multiple restrictions (expensive charges for publication fees, access to research funds, high travel and training costs, and visa access, among others).70 Strengthening health care infrastructure and systems Upgrades to health care facilities should leverage existing primary health care facilities and infectious disease infrastructure, particularly in underserved areas. Funding should come from governments, international organizations, and the private sector, prioritizing high-impact interventions. Universal health care coverage is needed for equitable CVD care access.71 CVH should be integrated into maternal, child, and infectious disease programs at the primary care level. Community health care professionals should be trained for routine screening, risk assessment, lifestyle counseling, and appropriate referrals. For example, community nurses in South Africa effectively perform ultrasound screenings for rheumatic heart disease,72 manage Group A Streptococcal infection, and promote better hygiene. Integrating cardiovascular risk assessment in regular visits for people with HIV or pregnant women is also feasible. Access to affordable, high-quality essential medicines at the primary care level through incentives provided to domestic pharmaceutical industries is crucial for efficiency. Fostering collaborations and partnerships Collaboration with international organizations such as the World Health Organization and nongovernmental organizations (NGOs) could leverage expertise and resources. Local governments, community leaders, and other stakeholders should be involved in planning and implementing cardiovascular prevention strategies to ensure cultural appropriateness and sustainability. Public-private partnerships can strengthen technical and financial capabilities in areas where the public sector is underdeveloped.71 Improving education and awareness National campaigns should use mass media, social media, and community events to increase awareness of cardiovascular risk factors. Local leaders, such as religious figures and celebrities, along with community organizations, should promote healthy behaviors and share health information during major events. Early education (pre- or primary-school) on hygiene should be expanded to include healthy eating and regular physical activity, for long-term health benefits.73 Advocating policy changes National and local policies should focus on cost-effective measures. Advocacy for political support and commitment is crucial.74 Then, raising awareness among policymakers can lead to stronger laws against tobacco and alcohol, new taxes on unhealthy foods, limits on TV ads for such products, regulations on multinational fast-food companies, and health promotion in school programs.75 In countries like Nigeria, Rwanda, and South Africa, these interventions were led by ministries of Health.76 In Malawi and Kenya, local NGOs, civil society organizations, and traditional leaders lobbied to initiate policies against industry influence.76 Regarding air pollution, policy decisions, like in Rwanda, should promote cleaner technologies, stricter emissions regulations, and initiatives to reduce the reliance on biomass for energy.77 Leveraging social media for influence and regular feedback from community leaders could also be beneficial. Leveraging technology and innovation Telemedicine can provide health education, consultations, and screenings to remote areas. For example, initial cardiac disease ultrasound screenings by nurses can be verified by specialists in real time. Enhancing internet access and technical infrastructure through private telecommunication companies, possibly with tax reductions, can support this. Companies could also offer free applications or short message services for follow-up and patient-health worker connections, adhering to ethical standards.78 Artificial intelligence-powered diagnostic and blockchain technology could, respectively, help professionals get faster accurate diagnoses and enhance transparency in health care transactions.71 Adapting to cultural beliefs and traditions Interventions should account for cultural and religious norms affecting CVD risk factors. In African communities, strategies should involve influential traditional leaders for public health education, address implementation barriers through qualitative research, and create culturally sensitive communication. For example, training “Bajenu gox” (neighborhood aunties, which is a traditional concept of female leadership) in Senegal, helped reduce neonatal and maternal deaths.79 Such local champions could equally enhance the prevention of pregnancy-related cardiovascular conditions, infant group A streptococcal infections, and promote healthy habits.79 Similarly, faith-based interventions hold the potential to facilitate CVH education, encourage lifestyle changes, and promote blood pressure checks in Nigeria.80 In Tanzania, priests and imams were trusted and enthusiastic potential partners, ready to receive and spread health education through religious texts promoting biomedical care.81 Conclusions CVDs remain a significant health burden in Africa, and effective preventive strategies are urgently needed to mitigate this burden. Challenges to implementing primordial prevention strategies include limited knowledge, resource and infrastructure constraints, limited research capacity, and sociocultural differences. Collaboration and partnerships among various national and international stakeholders (NGOs, health care professionals, community members) are essential for high-quality epidemiological research, effective public advocacy for national policies, improved health literacy, and strong primary health care. Implementing primordial prevention in Africa can significantly reduce CVD, improve quality of life, boost productivity, lower health costs, and prevent other NCDs. Promoting CVH and preventing these diseases in Africa is achievable with focused effort and collaboration. Funding support and author disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Footnotes The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. References